138 related articles for article (PubMed ID: 37467950)
21. Propensity-score-based priors for Bayesian augmented control design.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2019 Mar; 18(2):223-238. PubMed ID: 30537087
[TBL] [Abstract][Full Text] [Related]
22. Ensuring exchangeability in data-based priors for a Bayesian analysis of clinical trials.
Lin J; Gamalo-Siebers M; Tiwari R
Pharm Stat; 2022 Mar; 21(2):327-344. PubMed ID: 34585501
[TBL] [Abstract][Full Text] [Related]
23. Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint.
Roychoudhury S; Neuenschwander B
Stat Med; 2020 Mar; 39(7):984-995. PubMed ID: 31985077
[TBL] [Abstract][Full Text] [Related]
24. Model feedback in Bayesian propensity score estimation.
Zigler CM; Watts K; Yeh RW; Wang Y; Coull BA; Dominici F
Biometrics; 2013 Mar; 69(1):263-73. PubMed ID: 23379793
[TBL] [Abstract][Full Text] [Related]
25. Propensity score stratified MAP prior and posterior inference for incorporating information across multiple potentially heterogeneous data sources.
Zhu AY; Roy D; Zhu Z; Sailer MO
J Biopharm Stat; 2024 Mar; 34(2):190-204. PubMed ID: 36882957
[TBL] [Abstract][Full Text] [Related]
26. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence.
Wang C; Rosner GL
Stat Med; 2019 Jun; 38(14):2573-2588. PubMed ID: 30883861
[TBL] [Abstract][Full Text] [Related]
27. Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies.
Lin J; Lin J
J Biopharm Stat; 2022 Jan; 32(1):53-74. PubMed ID: 33998364
[TBL] [Abstract][Full Text] [Related]
28. Cutting feedback in Bayesian regression adjustment for the propensity score.
McCandless LC; Douglas IJ; Evans SJ; Smeeth L
Int J Biostat; 2010; 6(2):Article 16. PubMed ID: 21972431
[TBL] [Abstract][Full Text] [Related]
29. How to perform prespecified subgroup analyses when using propensity score methods in the case of imbalanced subgroups.
Chatelet F; Verillaud B; Chevret S
BMC Med Res Methodol; 2023 Oct; 23(1):255. PubMed ID: 37907863
[TBL] [Abstract][Full Text] [Related]
30. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Odani M; Fukimbara S; Sato T
Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
[TBL] [Abstract][Full Text] [Related]
31. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
Loux TM
Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
[TBL] [Abstract][Full Text] [Related]
32. The power prior with multiple historical controls for the linear regression model.
Banbeta A; Lesaffre E; van Rosmalen J
Pharm Stat; 2022 Mar; 21(2):418-438. PubMed ID: 34851549
[TBL] [Abstract][Full Text] [Related]
33. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
34. A Bayesian nonparametric test of significance chasing biases.
Karabatsos G
Res Synth Methods; 2018 Mar; 9(1):51-61. PubMed ID: 28985020
[TBL] [Abstract][Full Text] [Related]
35. Controlling for confounding via propensity score methods can result in biased estimation of the conditional AUC: A simulation study.
Galadima HI; McClish DK
Pharm Stat; 2019 Oct; 18(5):568-582. PubMed ID: 31111682
[TBL] [Abstract][Full Text] [Related]
36. The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials.
Saville BR; Berry DA; Berry NS; Viele K; Berry SM
Clin Trials; 2022 Oct; 19(5):490-501. PubMed ID: 35993547
[TBL] [Abstract][Full Text] [Related]
37. When does measurement error in covariates impact causal effect estimates? Analytic derivations of different scenarios and an empirical illustration.
Sengewald MA; Steiner PM; Pohl S
Br J Math Stat Psychol; 2019 May; 72(2):244-270. PubMed ID: 30345554
[TBL] [Abstract][Full Text] [Related]
38. An imputation-based solution to using mismeasured covariates in propensity score analysis.
Webb-Vargas Y; Rudolph KE; Lenis D; Murakami P; Stuart EA
Stat Methods Med Res; 2017 Aug; 26(4):1824-1837. PubMed ID: 26037527
[TBL] [Abstract][Full Text] [Related]
39. A Bayesian nonparametric approach to causal inference on quantiles.
Xu D; Daniels MJ; Winterstein AG
Biometrics; 2018 Sep; 74(3):986-996. PubMed ID: 29478267
[TBL] [Abstract][Full Text] [Related]
40. The role of prediction modeling in propensity score estimation: an evaluation of logistic regression, bCART, and the covariate-balancing propensity score.
Wyss R; Ellis AR; Brookhart MA; Girman CJ; Jonsson Funk M; LoCasale R; Stürmer T
Am J Epidemiol; 2014 Sep; 180(6):645-55. PubMed ID: 25143475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
